Stay updated on Carfilzomib Combo for Myeloma Clinical Trial
Sign up to get notified when there's something new on the Carfilzomib Combo for Myeloma Clinical Trial page.

Latest updates to the Carfilzomib Combo for Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new site revision (v3.4.2) was added and an older funding/operational status notice (v3.4.1) was removed; no core study details appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA government-funding notice banner was added and the site was updated to revision v3.4.1; the study details page content remains unchanged.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary display, a new QC status line 'Last Update Submitted that Met QC Criteria', and a 'No FEAR Act Data' label, along with updating the revision to v3.4.0. The older 'Last Update Submitted that met QC Criteria', lowercase 'No FEAR Act data', and the previous 'Revision: v3.3.4' text have been removed.SummaryDifference0.2%

- Check35 days agoChange DetectedRelated topics sections for 'Multiple Myeloma' and 'MedlinePlus Genetics' were removed. These are supplementary resources and do not alter core study details.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics. Page revision updated from v3.3.3 to v3.3.4.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page no longer lists the disease topic 'Multiple myeloma' and related topics such as MedlinePlus Genetics under the related topics section. This removes key disease context and reference resources from the page.SummaryDifference0.1%

Stay in the know with updates to Carfilzomib Combo for Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carfilzomib Combo for Myeloma Clinical Trial page.